首页> 外文会议>International Symposium on Industrial Crystallization >Preparation of composite particles comprised of antifungal drug and new additive agent for dry powder inhalation by crystallization during spray drying
【24h】

Preparation of composite particles comprised of antifungal drug and new additive agent for dry powder inhalation by crystallization during spray drying

机译:通过在喷雾干燥期间通过结晶制备由抗真菌药物和新添加剂的复合颗粒组成的复合颗粒,用于干燥粉末吸入

获取原文

摘要

The remarkable advancement of antifungal drugs has many infectious diseases overcome. The emerging infectious disease named as a new strain of influenza has appeared and resistant strain such as Methicillin-Resistant Staphylococcus Aureus (MRSA) and Multiple-Drug-Resistant Pseudomonas aeruginosa (MDRP) has increased. There remains unanswered with regard to increasing MRSA and MDRP. We should find out a new approach to solve out these remaing prolblems since the development of new antifungal drugs is extremely difficult. Some applications of pharmaceutical technology has been just attemptted to develop the new technology, which is more effective and safer compared to existing antifungal drugs.
机译:抗真菌药物的显着进步克服了许多传染病。被称为新的流感菌株的新出现的传染病出现了耐药菌株,例如耐甲氧西林金黄色葡萄球菌(MRSA)和多重耐药的假单胞菌铜绿假单胞菌(MDRP)增加。关于增加MRSA和MDRP,仍然没有答案。由于新的抗真菌药物的发展极为困难,我们应该找到一种新的方法来解决这些准确的争吵。药物技术的一些应用只是尝试开发新技术,与现有的抗真菌药物相比,更有效和更安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号